# Johannes F.E. Mann

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/johannes-f-e-mann/

## Facts

| Field | Value |
| --- | --- |
| Citations | 48,556 |
| Field | Diabetes Treatment and Management |
| h-index | 86 |
| i10-index | 228 |
| Last Known Institution | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| OpenAlex ID | https://openalex.org/A5043842967 |
| ORCID iD | 0000-0002-3154-5332 |
| Works | 433 |

## Researcher papers

Showing 12 of 25.

- [Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/liraglutide-and-cardiovascular-outcomes-in-type-2-diabetes/)
- [Dapagliflozin in Patients with Chronic Kidney Disease](https://scholariq.org/papers/dapagliflozin-in-patients-with-chronic-kidney-disease/)
- [Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis](https://scholariq.org/papers/atorvastatin-in-patients-with-type-2-diabetes-mellitus-undergoing-hemodialysis/)
- [Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention](https://scholariq.org/papers/chronic-kidney-disease-and-cardiovascular-risk-epidemiology-mechanisms-and/)
- [Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency](https://scholariq.org/papers/effect-of-the-angiotensin-converting-enzyme-inhibitor-benazepril-on-the/)
- [Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes](https://scholariq.org/papers/effects-of-semaglutide-on-chronic-kidney-disease-in-patients-with-type-2/)
- [Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial](https://scholariq.org/papers/renal-outcomes-with-telmisartan-ramipril-or-both-in-people-at-high-vascular-risk/)
- [Chronic Kidney Disease](https://scholariq.org/papers/chronic-kidney-disease/)
- [KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease](https://scholariq.org/papers/kdigo-2021-clinical-practice-guideline-for-the-management-of-blood-pressure-in/)
- [Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial](https://scholariq.org/papers/renal-insufficiency-as-a-predictor-of-cardiovascular-outcomes-and-the-impact-of/)
- [Liraglutide and Renal Outcomes in Type 2 Diabetes](https://scholariq.org/papers/liraglutide-and-renal-outcomes-in-type-2-diabetes/)
- [Intensive Supportive Care plus Immunosuppression in IgA Nephropathy](https://scholariq.org/papers/intensive-supportive-care-plus-immunosuppression-in-iga-nephropathy/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

## Researcher university

- [Friedrich-Alexander-Universität Erlangen-Nürnberg](https://scholariq.org/institutions/friedrich-alexander-universitat-erlangen-nurnberg/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.